Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank Drug (Description in trials) KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1 Bevacizumab
(Bevacizumab)		[1] Bevacizumab[1] Bevacizumab (Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab, Bevacizumab-awwb, Bevacizumab-bvzr, Bevacizumab-maly, Bevacizumab-adcd, Bevacizumab-tnjn, Bevacizumab-nwgd) 💬 [1] VEGFA 💬 [23] AGE-RAGE signaling pathway in diabetic complications, Bladder cancer, Calcium signaling pathway, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Fluid shear stress and atherosclerosis, Focal adhesion, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, MAPK signaling pathway, MicroRNAs in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, VEGF signaling pathway 💬[8] 13, 34, 85, 87, 89, 227, 280, 331 💬
2 Bevacizumab zirconium Zr-89
(Bevacizumab zirconium Zr-89)		[2] 89ZR-bevacizumab; Bevacizumab zirconium ZR-89---[1] 34 💬